Billroth II anastomosis combined with brown anastomosis reduce reflux gastritis in gastric cancer patients

Table 1 Study outcomes

	Operation	n	Mean	SD	P value
Postoperative hospitalization days	Billroth II	74	13.09	1.41	< 0.0001
	Billroth II + Braun	28	10.17	2.01
Feeding start day	Billroth II	74	6.33	0.66	< 0.0001
	Billroth II + Braun	28	5.17	0.41
NGT removal day	Billroth II	74	4.31	0.31	< 0.0001
	Billroth II + Braun	28	4.00	0.67
NGT output (day 0)	Billroth II	74	183.56	56.29	< 0.0001
	Billroth II + Braun	26	73.64	25.70
NGT output (day 1)	Billroth II	72	265.80	50.08	< 0.0001
	Billroth II + Braun	26	168.18	76.95
NGT output (day 2)	Billroth II	61	234.59	44.82	< 0.0001
	Billroth II + Braun	21	85.56	43.08
NGT output (day 3)	Billroth II	49	280.00	57.76	< 0.0001
	Billroth II + Braun	16	47.14	17.82
NGT output (day 4)	Billroth II	30	251.67	70.48	< 0.0001
	Billroth II + Braun	12	136.00	93.25
NGT output (day 5)	Billroth II	21	234.62	65.08	< 0.0001
	Billroth II + Braun	7	116.67	92.80
NGT output (day 6)	Billroth II	13	322.50	76.11	< 0.0001
	Billroth II + Braun	1	0	NA
NGT output (sum)	Billroth II	74	1102.78	203.94	< 0.0001
	Billroth II + Braun	28	399.17	140.18

NGT: Nasogastric tube; NA: Not available.

Table 2 Postoperative complications

Postoperative complications	Billroth II	Billroth II with Braun	P value
Bile reflux	40	9	0.048
Alkaline gastritis	40	9	0.048
Anastomotic bleeding	2	1	0.820
Anastomotic fistula	1	1	0.470

Table 3 Patients’ characteristics

Characteristics	Billroth II	Billroth II and Braun
Age	70.75	70.41
Gender
Male	44	21
Female	30	7
Operation time (min)	226.4 ± 41.6	255.8 ± 66.2
Blood loss (mL)	175.4 ± 121.3	148.7 ± 96.8

Table 4 Aligned Rank Transform three-way ANOVA results (P < 0.05)

	NGT output (sum)	Postoperative hospitalization days
Age	0.929	0.339
Gender	0.325	0.093
Method	0.170	0.469
Interaction age and gender	0.861	0.288
Interaction age and method	0.946	0.635
Interaction gender and method	0.579	0.177
Interaction age, gender, and method	0.983	0.998

NGT: Nasogastric tube.